Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban in Chinese Children With Giant Coronary Artery Aneurysm After Kawasaki Disease
NCT06978439Phase 4Recruiting
- Sponsor
- Children's Hospital of Fudan University
- Start
- Jan 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in coronary artery aneurysm (CAA), sponsored by Children's Hospital of Fudan University. Started Jan 2024; status: recruiting.
02
Drugs
rivaroxaban
03
Conditions
coronary artery aneurysm (CAA)
Beyond the preview
Go deeper on NCT06978439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06978439.